Potential survival gains from first-line (1L) systemic therapy advances in metastatic triple-negative breast cancer (mTNBC)P. Bajaj,J.A. Roth, S.D. Sullivan, A. Stein, R. Mahtani,S.D. RamseyAnnals of Oncology（2018）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
